Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2008
01/08/2008CA2225183C Novel foam proteins and use thereof
01/08/2008CA2181164C Anti-gram-positive bacterial methods and materials
01/08/2008CA2145826C Lipopeptide derivatives, a process for their preparation and their use
01/08/2008CA2128794C Mutant aox2 promoter, vector carrying same, transformant, and production of heterologous protein
01/08/2008CA2116179C Verotoxin pharmaceutical compositions and medical treatments therewith
01/08/2008CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
01/04/2008CA2595164A1 An antibody which recognizes phosphorylated polypeptides
01/04/2008CA2591804A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases
01/04/2008CA2557772A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases
01/04/2008CA2551537A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases
01/03/2008WO2008002872A2 Soybean event 3560.4.3.5 and compositions and methods for the identification and/or detection thereof
01/03/2008WO2008002157A1 Apyrases and uses thereof
01/03/2008WO2008002153A2 Novel polypeptides
01/03/2008WO2008001944A1 Reagent for detection of autoantibody and kit for diagnosis of autoimmune disease
01/03/2008WO2008001888A1 Method for pre-treatment of serum for analysis of sugar chain
01/03/2008WO2008001498A1 Model animal of dendritic cell immunoreceptor gene knockout disease
01/03/2008WO2008001376A2 Detection of analytes in a medium
01/03/2008WO2008001126A2 Compositions and methods relating to cellular targeting
01/03/2008WO2008000881A1 Glycosylated human alpha interferon muteins, method for obtaining them and use
01/03/2008WO2008000803A1 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease
01/03/2008WO2008000516A2 Improved sgp130fc dimers
01/03/2008WO2008000512A2 Method for identifying crmp modulators
01/03/2008WO2008000186A1 A method for identifying novel gene and the resulting novel genes
01/03/2008WO2008000079A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers
01/03/2008WO2008000028A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
01/03/2008WO2007129093A3 Hla peptide therapy
01/03/2008WO2007129077A3 Imaging agent
01/03/2008WO2007117467A3 Use of tm-601 for the diagnosis and treatment of tumors
01/03/2008WO2007112940A3 Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same
01/03/2008WO2007110231A3 MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
01/03/2008WO2007107488A3 Vaccine against trypanosoma cruzi infection
01/03/2008WO2007106121A3 Design and construction of dimeric concanavalin a mutants
01/03/2008WO2007104934A3 Protein folding
01/03/2008WO2007102174A3 Process for preparing human g-csf
01/03/2008WO2007100584A3 Antiviral agents and vaccines against influenza
01/03/2008WO2007087178A3 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same
01/03/2008WO2007082105A3 Chlamydia vaccine
01/03/2008WO2007081419A3 Compositions and methods related to anti-fgf agents
01/03/2008WO2007067681A3 Immunostimulatory compositions and methods
01/03/2008WO2007060550A3 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
01/03/2008WO2007051077A3 Methods and compounds for lymphoma cell detection and isolation
01/03/2008WO2007047763A3 Bcr-abl vaccines and methods of use thereof
01/03/2008WO2006114308A8 Carrier for targeting nerve cells
01/03/2008WO2006109174A3 Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid
01/03/2008WO2006085769A3 Methods and means for determining and conferring stress tolerance in plants
01/03/2008WO2005118857A3 Methods and agents for screening for compounds capable of modulating vegf expression
01/03/2008WO2005079232A3 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK
01/03/2008WO2005033130A3 Mutated ig binding domains of protein l
01/03/2008WO2005032476A3 Methods and compositions for cpg15-2
01/03/2008WO2003095473A3 Peptides and methods for cell death regulation
01/03/2008WO2003085085A3 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
01/03/2008WO2003083099A3 Purified polypeptides involved in protein synthesis and modification
01/03/2008US20080005813 Polypeptide Having Function of Cinnamyl Alcohol Dehydrogenase, Polynucleotide Encoding the Polypeptide and Those Uses
01/03/2008US20080004437 Cloned Genes Encoding Reverse Transcriptase lacking RNase H Activity
01/03/2008US20080004435 Corticotropin releasing factor 2 receptor agonists
01/03/2008US20080004433 Characterization of the GSK-3beta protein and methods of use thereof
01/03/2008US20080004432 HEMCM42 antibodies
01/03/2008US20080004431 Method of manufacturing an injectable collagen material
01/03/2008US20080004430 CNG3B: a novel cyclic nucleotide-gated cation channel
01/03/2008US20080004428 A neuregulin, epidermal growth factor, ligands for the ErbB/HER receptors; detecting EGFH2 polypeptides or mRNA for diagnostic and prognostic purposes; anticarcinogenic agents; antitumor agents; pancreatic cancer/tumor
01/03/2008US20080004326 Method of Obtaining Idolocarbazoles Using Biosynthetic Rebeccamycin Genes
01/03/2008US20080004231 Disease-Associated Protein
01/03/2008US20080004229 Methods and Compositions Related to Skcg-1, a Tumor Suppressor
01/03/2008US20080004227 Pharmaceutical Composition for Lowering Blood Sugar Level
01/03/2008US20080004221 High Molecular Weight Derivatives of Vitamin K-Dependent Polypeptides
01/03/2008US20080004220 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
01/03/2008US20080004219 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms
01/03/2008US20080004216 Modified vitamin K-dependent polypeptides
01/03/2008US20080004212 Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
01/03/2008US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof
01/03/2008US20080004206 Albumin fusion proteins
01/03/2008US20080004205 Ultrafiltration membranes and methods of making
01/03/2008US20080003695 Enriched Pag-55 Fraction and Methods for Early Detection of Preganancy in Ungulate Animals
01/03/2008US20080003683 Ce7-specific redirected immune cells
01/03/2008US20080003680 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories
01/03/2008US20080003675 Methods and compositions for identifying morphogen analogs
01/03/2008US20080003630 Tyrosine kinse substrate
01/03/2008US20080003619 Novel proteins with enhanced functionality and methods of making novel proteins using circular permutation
01/03/2008US20080003318 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms
01/03/2008US20080003243 Oral Anti-Protozoiasis Vaccines Based on Transgenic Plants
01/03/2008US20080003235 Vaccine Composition Comprising a Class II Cmh Lignd Coupled With an Antigen, Method for the Preparation and the Use Thereof
01/03/2008US20080003233 Recombinant Vaccines Against Caligid Copepods (Sea Lice) and Antigen Sequences Thereof
01/03/2008US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine
01/03/2008US20080003228 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen
01/03/2008US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof
01/03/2008US20080003223 Babesia canis vaccine
01/03/2008US20080003212 ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor
01/03/2008US20080003202 Modified interferon-beta (IFN-beta) polypeptides
01/03/2008DE60219221T2 DNS-Sequenzen mit anti-repressor Aktivität DNA sequences with anti-repressor activity
01/03/2008DE3890998B4 Neutrophilenaktivierungsfaktor, Verfahren zu seiner Herstellung und ihn enthaltende pharmazeutische Zusammensetzung Neutrophilenaktivierungsfaktor, process for its preparation and pharmaceutical composition containing it
01/03/2008CA2656474A1 Polypeptides from neisseria meningitidis
01/03/2008CA2656440A1 Improved sgp130fc dimers
01/03/2008CA2655849A1 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease
01/03/2008CA2655685A1 Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions
01/03/2008CA2653756A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers
01/03/2008CA2652957A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
01/02/2008EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof
01/02/2008EP1873244A2 Methods and compositions for inhibiting neoplastic cell growth
01/02/2008EP1873239A1 Gene capable of controlling differentiation/growth of plant, and use of the same
01/02/2008EP1873166A1 Improved sgp 130Fc dimers